2016
DOI: 10.1186/s12967-016-1065-8
|View full text |Cite
|
Sign up to set email alerts
|

An ex vivo human cartilage repair model to evaluate the potency of a cartilage cell transplant

Abstract: BackgroundCell-based therapies such as autologous chondrocyte implantation are promising therapeutic approaches to treat cartilage defects to prevent further cartilage degeneration. To assure consistent quality of cell-based therapeutics, it is important to be able to predict the biological activity of such products. This requires the development of a potency assay, which assesses a characteristic of the cell transplant before implantation that can predict its cartilage regeneration capacity after implantation… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

2
38
1

Year Published

2018
2018
2024
2024

Publication Types

Select...
9

Relationship

1
8

Authors

Journals

citations
Cited by 38 publications
(41 citation statements)
references
References 27 publications
2
38
1
Order By: Relevance
“…Only 12-26 weeks after implantation of the single cell suspension, cartilage matrix develops (Becher et al, 2017;Krill et al, 2018). The major advantage of using spheroids instead of single cells is that, because of the high cell-cell contacts and cell density in 3D preculture, they already have developed a tissue specific ECM, before they are used for implantation (Bartz et al, 2016;De Moor et al, 2019). We believe the use of spheroids will lead to a less fibrous tissue than traditional ACI because they already possess a GAG-and collagen II-rich ECM.…”
Section: Discussionmentioning
confidence: 99%
“…Only 12-26 weeks after implantation of the single cell suspension, cartilage matrix develops (Becher et al, 2017;Krill et al, 2018). The major advantage of using spheroids instead of single cells is that, because of the high cell-cell contacts and cell density in 3D preculture, they already have developed a tissue specific ECM, before they are used for implantation (Bartz et al, 2016;De Moor et al, 2019). We believe the use of spheroids will lead to a less fibrous tissue than traditional ACI because they already possess a GAG-and collagen II-rich ECM.…”
Section: Discussionmentioning
confidence: 99%
“…These results argue for an advantage of cell-loaded versus cell-free collagen implants, in agreement with earlier studies on cellseeded or cell-containing implants based on collagen or other cartilage replacement materials. [41][42][43][44] Alternatively, in vivo microfracturing of the subchondral bone plate below the cartilage implant can be used to favor cell immigration into initially cell-free implants and optimize the conditions for successful cartilage repair. 39,40,45 Cell-free and cell-loaded collagen implants both showed progressive deposition of the matrix molecule aggrecan and a stable protein content of collagen 2 throughout culture, again demonstrating the cytocompatibility of the implant material and the active production of cartilage-specific matrix molecules by vital chondrocytes.…”
Section: Discussionmentioning
confidence: 99%
“…GAG secretion was analysed with standard 1,9-dimethylmethylene blue assay using chondroitin sulphate sodium salt from shark (Sigma-Aldrich) to generate standard curves as described before [ 19 ]. Standard and samples of each donor were measured in triplicates.…”
Section: Methodsmentioning
confidence: 99%